Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Update on Glaxo's Vaccine Portfolio
Yahoo/Zacks
Wednesday, October 30, 2013 - 10:09am
tags:
GSK, vaccines, Synflorix
Pernix Co-Promotes with Cumberland
Yahoo/Zacks
Wednesday, October 30, 2013 - 10:07am
tags:
Pernix, Cumberland, Omeclamox-Pak, H pylori
Teva Pharmaceuticals: Copaxone's Upcoming Expiration Continues To Depress Its Current Valuation
Seeking Alpha
Wednesday, October 30, 2013 - 10:05am
tags:
Teva, MS, multiple sclerosis, Copaxone
FDA Throws More Cold Water On Amarin's Hopes For Vascepa
Forbes
Wednesday, October 30, 2013 - 10:03am
tags:
FDA, Amarin, Vascepa
Teva CEO Levin to Step Down After Reported Board Feud
Bloomberg
Wednesday, October 30, 2013 - 10:02am
tags:
Teva, Jeremy Levin, Pharma CEOs
Dendreon Grasps for Bid as Main Drug Burns Cash: Real M&A
Bloomberg
Wednesday, October 30, 2013 - 9:52am
tags:
M&A, Dendreon
Arena's Belviq Refills Week 19
Seeking Alpha
Wednesday, October 30, 2013 - 9:51am
tags:
Arena Pharmaceuticals, Belviq, Eisai
Gilead Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Yahoo/Seeking Alpha
Wednesday, October 30, 2013 - 9:46am
tags:
Gilead Sciences, earnings
MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
Yahoo/Fly on the Wall
Wednesday, October 30, 2013 - 9:45am
tags:
diabetes, inhaled insulin, MannKind, FDA, Afrezza
Sanofi Profit Forecast Eases Concern After Setbacks
Bloomberg
Wednesday, October 30, 2013 - 9:42am
tags:
Sanofi, guidance
Short Sarepta: DMD Drug Prognosis Is Dismal
Seeking Alpha
Wednesday, October 30, 2013 - 9:35am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Xenoport, Questcor, and NuVasive Could Be Big Movers Today
Motley Fool
Wednesday, October 30, 2013 - 9:34am
tags:
XenoPort, Questcor, NuVasive, XP23829, Pain Therapeutics, Horizant
NeoStem: Major Developments You Might Have Missed
Seeking Alpha
Wednesday, October 30, 2013 - 9:31am
tags:
NeoStem, stem cells, PCT
Pfizer Profit Gets Help From Cancer-Fighting Unit
Forbes
Tuesday, October 29, 2013 - 12:45pm
tags:
Pfizer, earnings, cancer, oncology
BMS rheumatoid arthritis drug clazakizumab causes a stir at ACR
Pharma Times, UK
Tuesday, October 29, 2013 - 12:14pm
tags:
rheumatoid arthritis, clazakizumab, Bristol-Myers Squibb
Boston Scientific reports data shows blood pressure reduction with Vessix
Yahoo/AP
Tuesday, October 29, 2013 - 12:11pm
tags:
Boston Scientific, hypertension, Vessix, devices
Moving Too Fast? Expedited Drug Approvals Raise Questions
Pharmalot
Tuesday, October 29, 2013 - 12:08pm
tags:
drug approvals, FDA
Doctors To HHS: Exclude Textbooks And Reprints From Sunshine Act, Or Else
Pharmalot
Tuesday, October 29, 2013 - 12:07pm
tags:
Physician Payment Sunshine Act, physicians, HHS
Actavis Q3 Merely In Line, But Stock Hits High
Investors.com
Tuesday, October 29, 2013 - 12:06pm
tags:
Actavis, earnings
Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?
Motley Fool
Tuesday, October 29, 2013 - 12:03pm
tags:
Dendreon, Sarepta Therapeutics, Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.